392 related articles for article (PubMed ID: 17548905)
1. Complicated parapneumonic effusion and empyema thoracis: microbiology and predictors of adverse outcomes.
Tsang KY; Leung WS; Chan VL; Lin AW; Chu CM
Hong Kong Med J; 2007 Jun; 13(3):178-86. PubMed ID: 17548905
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors, microbiology and outcome of patients with parapneumonic effusion.
Falguera M; Carratalà J; Bielsa S; García-Vidal C; Ruiz-González A; Chica I; Gudiol F; Porcel JM
Eur Respir J; 2011 Nov; 38(5):1173-9. PubMed ID: 21565916
[TBL] [Abstract][Full Text] [Related]
3. Intrapleural streptokinase for the treatment of complicated parapneumonic effusion and empyema in 2 newborns.
Yigit AK; Yilmaz Y; Erdeve O; Gokce IK; Oguz SS; Uras N; Dilmen U
J Pediatr Surg; 2012 Oct; 47(10):e41-4. PubMed ID: 23084230
[TBL] [Abstract][Full Text] [Related]
4. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema.
Singh G; Pitoyo CW; Nasir AU; Rumende CM; Amin Z
Acta Med Indones; 2012 Jul; 44(3):258-64. PubMed ID: 22983084
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials.
Nie W; Liu Y; Ye J; Shi L; Shao F; Ying K; Zhang R
Clin Respir J; 2014 Jul; 8(3):281-91. PubMed ID: 24428897
[TBL] [Abstract][Full Text] [Related]
6. Early use of intrapleural fibrinolytics in the management of postpneumonic empyema. A prospective study.
Misthos P; Sepsas E; Konstantinou M; Athanassiadi K; Skottis I; Lioulias A
Eur J Cardiothorac Surg; 2005 Oct; 28(4):599-603. PubMed ID: 16129614
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia.
Chalmers JD; Singanayagam A; Murray MP; Scally C; Fawzi A; Hill AT
Thorax; 2009 Jul; 64(7):592-7. PubMed ID: 19131449
[TBL] [Abstract][Full Text] [Related]
8. Treatment of complicated parapneumonic pleural effusion with intrapleural streptokinase in children.
Yao CT; Wu JM; Liu CC; Wu MH; Chuang HY; Wang JN
Chest; 2004 Feb; 125(2):566-71. PubMed ID: 14769739
[TBL] [Abstract][Full Text] [Related]
9. Benefit of intrapleural fibrinolytic therapy in the treatment of complicated parapneumonic effusion and empyema.
Merhabene T; Zayet S; Jamoussi A; Ayed S; Mansouri S; Khelil JB; Besbes M
Pan Afr Med J; 2024; 47():54. PubMed ID: 38646137
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy in complicated parapneumonic pleural effusions and thoracic empyema.
Schiza SE; Antoniou KM; Economidou FN; Siafakas NM
Pulm Pharmacol Ther; 2005; 18(6):381-9. PubMed ID: 15998594
[TBL] [Abstract][Full Text] [Related]
11. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
Khemasuwan D; Sorensen J; Griffin DC
Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674
[TBL] [Abstract][Full Text] [Related]
12. Complicated parapneumonic effusion and empyema in children.
Shen YH; Hwang KP; Niu CK
J Microbiol Immunol Infect; 2006 Dec; 39(6):483-8. PubMed ID: 17164951
[TBL] [Abstract][Full Text] [Related]
13. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study.
Bouros D; Schiza S; Patsourakis G; Chalkiadakis G; Panagou P; Siafakas NM
Am J Respir Crit Care Med; 1997 Jan; 155(1):291-5. PubMed ID: 9001327
[TBL] [Abstract][Full Text] [Related]
14. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis.
Tokuda Y; Matsushima D; Stein GH; Miyagi S
Chest; 2006 Mar; 129(3):783-90. PubMed ID: 16537882
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic treatment of patients with pneumonia and pleural effusion.
Teixeira LR; Villarino MA
Curr Opin Pulm Med; 1998 Jul; 4(4):230-4. PubMed ID: 10813239
[TBL] [Abstract][Full Text] [Related]
16. Intrapleural fibrinolytic therapy in complicated parapneumonic effusion and empyema: present status.
Barthwal MS
Indian J Chest Dis Allied Sci; 2008; 50(3):277-82. PubMed ID: 18630794
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolytics in the treatment of parapneumonic effusions.
Bouros D; Schiza S; Siafakas N
Monaldi Arch Chest Dis; 1999 Jun; 54(3):258-63. PubMed ID: 10441983
[TBL] [Abstract][Full Text] [Related]
18. Intrapleural streptokinase treatment in children with empyema.
Aydoğan M; Aydoğan A; Ozcan A; Tugay M; Gokalp AS; Arisoy ES
Eur J Pediatr; 2008 Jul; 167(7):739-44. PubMed ID: 17710434
[TBL] [Abstract][Full Text] [Related]
19. Seventeen-year study shows rise in parapneumonic effusion and empyema with higher treatment failure after chest tube drainage.
Yu D; Buchvald F; Brandt B; Nielsen KG
Acta Paediatr; 2014 Jan; 103(1):93-9. PubMed ID: 24117621
[TBL] [Abstract][Full Text] [Related]
20. Complicated parapneumonic effusion and empyema thoracis: microbiologic and therapeutic aspects.
Ozol D; Oktem S; Erdinc E
Respir Med; 2006 Feb; 100(2):286-91. PubMed ID: 15998584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
